Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Foldax
company
About
Foldax is engages in synthetic heart valve development to deliver non-thrombogenic aortic and mitral valves at dramatically lower cost.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $20M
- Industries
- Developer Platform,Manufacturing,Medical Device
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Foldax is developing synthetic heart valves with the goal of delivering non-thrombogenic aortic and mitral valves at dramatically lower costs to existing artificial or tissue valves. It operates in the manufacturing sector. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20M
Foldax has raised a total of
$20M
in funding over 2 rounds. Their latest funding was raised on
Jun 22, 2020 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 22, 2020 | Series D | $20M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Foldax is funded by 2 investors.
Sayan Bioventures
and Angel Physicians Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
